In summary, we have explored the crucial roles of angiogenesis and immunity in the onset and progression of ILD and COPD, and we identified COL10A1, EDN1, MMP1, and RRAS as potential novel therapeutic targets for chronic lung diseases. This evidence concerns the gene EDN1 and interstitial lung disease.